Arijit Sarkar 
Dealstreet

Khaitan & Co advises HDFC Bank on providing ₹500 crore financing to Maiva Pharma

The funds will be utilised for a greenfield project for manufacturing of sterile injectables.

Bar & Bench

HDFC Bank Limited has granted a Rupee facility aggregating to ₹500 crore, with a non-fund based sublimit in form of letter of credit facility to Maiva Lifesciences Private Limited and Maiva Pharma Private Limited.

Khaitan & Co advised HDFC Bank on this transaction.

The transaction team consisted of Arijit Sarkar (Partner), Chirag Gohil (Senior Associate), Siddhant Shetty (Senior Associate) and Charul Lunia (Associate).

Maiva Pharma

Starting operations in 1996, Maiva Pharma has two decades of experience in manufacturing Sterile Injectables. The company manufactures sterile solutions in vials and ampoules and has lyophilization capability as well.

The funds will be utilised for a greenfield project for manufacturing of sterile injectables. 

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Also Read

P&H High Court sets June 19 deadline for completion of north India’s largest court complex in Gurugram

Supreme Court flags poor conviction rate in UAPA cases, 94-98 percent trials end in acquittal

Supreme Court refuses PIL on minimum wages for priests in State temples

Nomination is not succession: Why a nominee does not always become the owner

Robert Vadra withdraws plea before Delhi High Court against summons in Shikohpur land deal case

SCROLL FOR NEXT